Model Independent Information On Solar Neutrino Oscillations

We present the results of a Bayesian analysis of solar neutrino data in terms of nu_e->nu_{mu,tau} oscillations, independent from the Standard Solar Model predictions for the solar neutrino fluxes. We show that such a model independent analysis allows to constraint the values of the neutrino mixing parameters in limited regions around the usual SMA, LMA, LOW and VO regions. Furthermore, there is a strong indication in favor of large neutrino mixing and large values of Delta m^2 (LMA region). We calculate also the allowed ranges of the neutrino fluxes and we show that they are in good agreement with the Standard Solar Model prediction. In particular, the ratio of the 8B flux with its Standard Solar Model prediction is constrained in the interval [0.45,1.42] with 99.73% probability. Finally, we show that the hypothesis of no neutrino oscillations is strongly disfavored in a model independent way with respect to the hypothesis of neutrino oscillations.Comment: 40 pages, 20 figures. Added references and improved figure

Kinetics and Jamming Coverage in a Random Sequential Adsorption of Polymer Chains

Using a highly efficient Monte Carlo algorithm, we are able to study the growth of coverage in a random sequential adsorption (RSA) of self-avoiding walk (SAW) chains for up to 10^{12} time steps on a square lattice. For the first time, the true jamming coverage (theta_J) is found to decay with the chain length (N) with a power-law theta_J propto N^{-0.1}. The growth of the coverage to its jamming limit can be described by a power-law, theta(t) approx theta_J -c/t^y with an effective exponent y which depends on the chain length, i.e., y = 0.50 for N=4 to y = 0.07 for N=30 with y -> 0 in the asymptotic limit N -> infinity.Comment: RevTeX, 5 pages inclduing figure

Parity violating target asymmetry in electron - proton scattering

We analyze the parity-violating (PV) components of the analyzing power in elastic electron-proton scattering and discuss their sensitivity to the strange quark contributions to the proton weak form factors. We point out that the component of the analyzing power along the momentum transfer is independent of the electric weak form factor and thus compares favorably with the PV beam asymmetry for a determination of the strangeness magnetic moment. We also show that the transverse component could be used for constraining the strangeness radius. Finally, we argue that a measurement of both components could give experimental information on the strangeness axial charge.Comment: 24 pages, Latex, 5 eps figures, submitted to Phys.Rev.

Moltemplate: a tool for coarse-grained modeling of complex biological matter and soft condensed matter physics

Macromolecular Biochemistr

The Phoenix galaxy as seen by NuSTAR

Aims. We study the long-term variability of the well-known Seyfert 2 galaxy Mrk 1210 (a.k.a. UGC 4203, or the Phoenix galaxy). Methods. The source was observed by many X-ray facilities in the last 20 years. Here we present a NuSTAR observation and put the results in context of previously published observations. Results. NuSTAR observed Mrk 1210 in 2012 for 15.4 ks. The source showed Compton-thin obscuration similar to that observed by Chandra, Suzaku, BeppoSAX and XMM-Newton over the past two decades, but different from the first observation by ASCA in 1995, in which the active nucleus was caught in a low flux state - or obscured by Compton-thick matter, with a reflection-dominated spectrum. Thanks to the high-quality hard X-ray spectrum obtained with NuSTAR and exploiting the long-term spectral coverage spanning 16.9 years, we can precisely disentangle the transmission and reflection components and put constraints on both the intrinsic long-term variability and hidden nucleus scenarios. In the former case, the distance between the reflector and the source must be at least ~ 2 pc, while in the latter one the eclipsing cloud may be identified with a water maser-emitting clump.<br/

Observation of Scaling Violations in Scaled Momentum Distributions at HERA

Charged particle production has been measured in deep inelastic scattering (DIS) events over a large range of $x$ and $Q^2$ using the ZEUS detector. The evolution of the scaled momentum, $x_p$, with $Q^2,$ in the range 10 to 1280 $GeV^2$, has been investigated in the current fragmentation region of the Breit frame. The results show clear evidence, in a single experiment, for scaling violations in scaled momenta as a function of $Q^2$.Comment: 21 pages including 4 figures, to be published in Physics Letters B. Two references adde

Punica granatum L. protects mice against hexavalent chromium-induced genotoxicity

This study investigated the chemoprotective effects of Punica granatum L. (Punicaceae) fruits alcoholic extract (PGE) on mice exposed to hexavalent chromium [Cr(VI)]. Animals were pretreated with PGE (25, 50 or 75 mg/kg/day) for 10 days and subsequently exposed to a sub-lethal dose of Cr(VI) (30 mg/kg). The frequency of micronucleated polychromatic erythrocytes in the bone marrow was investigated and the Cr(VI) levels were measured in the kidneys, liver and plasm. For the survival analysis, mice were previously treated with PGE for 10 days and exposed to a single lethal dose of Cr(VI) (50 mg/kg). Exposure to a sub-lethal dose of Cr(VI) induced a significant increase in the frequency of micronucleated cells. However, the prophylactic treatment with PGE led to a reduction of 44.5% (25 mg/kg), 86.3% (50 mg/kg) and 64.2% (75 mg/kg) in the incidence of micronuclei. In addition, the 50 mg/kg dose of PGE produced a higher chemoprotective effect, since the survival rate was 90%, when compared to that of the non-treated group. In these animals, reduced amounts of chromium were detected in the biological materials, in comparison with the other groups. Taken together, the results demonstrated that PGE exerts a protective effect against Cr(VI)-induced genotoxicity

A selective ATP-binding cassette subfamily G member 2 efflux inhibitor revealed via high-throughput flow cytometry

Chemotherapeutics tumor resistance is a principal reason for treatment failure, and clinical and experimental data indicate that multidrug transporters such as ATP-binding cassette (ABC) B1 and ABCG2 play a leading role by preventing cytotoxic intracellular drug concentrations. Functional efflux inhibition of existing chemotherapeutics by these pumps continues to present a promising approach for treatment. A contributing factor to the failure of existing inhibitors in clinical applications is limited understanding of specific substrate/inhibitor/pump interactions. We have identified selective efflux inhibitors by profiling multiple ABC transporters against a library of small molecules to find molecular probes to further explore such interactions. In our primary screening protocol using JC-1 as a dual-pump fluorescent reporter substrate, we identified a piperazine-substituted pyrazolo[1,5-a]pyrimidine substructure with promise for selective efflux inhibition. As a result of a focused structure-activity relationship (SAR)-driven chemistry effort, we describe compound 1 (CID44640177), an efflux inhibitor with selectivity toward ABCG2 over ABCB1. Compound 1 is also shown to potentiate the activity of mitoxantrone in vitro as well as preliminarily in vivo in an ABCG2-overexpressing tumor model. At least two analogues significantly reduce tumor size in combination with the chemotherapeutic topotecan. To our knowledge, low nanomolar chemoreversal activity coupled with direct evidence of efflux inhibition for ABCG2 is unprecedented

Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations. Material and methods: A retrospective, descriptive, and observational study was conducted on adults hospitalised due to COVID-19 in Spain who were included in the SEMI-COVID- 19 Registry from March to November 2020. Results: CTs were used in 6053 (36.21%) of the included patients. The patients were older (mean (SD)) (69.6 (14.6) vs. 66.0 (16.8) years; p < 0.001), with hypertension (57.0% vs. 47.7%; p < 0.001), obesity (26.4% vs. 19.3%; p < 0.0001), and multimorbidity prevalence (20.6% vs. 16.1%; p < 0.001). These patients had higher values (mean (95% CI)) of C-reactive protein (CRP) (86 (32.7-160) vs. 49.3 (16-109) mg/dL; p < 0.001), ferritin (791 (393-1534) vs. 470 (236- 996) µg/dL; p < 0.001), D dimer (750 (430-1400) vs. 617 (345-1180) µg/dL; p < 0.001), and lower Sp02/Fi02 (266 (91.1) vs. 301 (101); p < 0.001). Since June 2020, there was an increment in the use of CTs (March vs. September; p < 0.001). Overall, 20% did not receive steroids, and 40% received less than 200 mg accumulated prednisone equivalent dose (APED). Severe patients are treated with higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%. Conclusions: Patients with greater comorbidity, severity, and inflammatory markers were those treated with CTs. In severe patients, there is a trend towards the use of higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%